Content of a collaborative drug therapy management agreement

A collaborative drug therapy management agreement shall include: (1) The types of prescriptive authority decisions the pharmacist may make (e.g., initiation, continuation or modification); (2) Patients who are eligible for treatment; (3) The types of diseases, drugs, or drug categories involved (there are no limitations on disease states or conditions); (4) The procedures, decision criteria, plans, or guidelines the pharmacist is to follow when making therapeutic decisions, particularly when initiating or modifying drug therapy; (5) Required training; (6) A plan for periodic review, feedback and quality assurance; and (7) Procedures for documenting prescribing decisions.